Document:

exv10w3

 

EXHIBIT 10.3

LETTER OF STOCK OPTION GRANT

ORTHOLOGIC CORP. 1997 STOCK OPTION PLAN

March 3, 2005

Dr. James M. Pusey

OrthoLogic Corp.

1275 West Washington

Tempe, Arizona 85281

		
	          RE: 	OrthoLogic Corp. 1997 Stock Option Plan

(200,000 shares)

Dear Dr. Pusey:

     In order to provide additional incentive to certain selected employees, OrthoLogic Corp. (the
“Company”) adopted the OrthoLogic 1997 Stock Option Plan (the “Stock Option Plan”). By means of
this letter, the Company is offering you an option pursuant to the Stock Option Plan. The
Company’s sale of its common shares underlying the option granted to you hereby has been registered
with the U.S. Securities and Exchange Commission. A copy of the prospectus including a copy of the
Stock Option Plan (the “Prospectus”) relating to that registration can be obtained from the Company
by request.

     The option granted to you hereunder shall be subject to all of the terms and conditions of the
Stock Option Plan, which you should carefully review. In addition, such option is subject to the
following terms and conditions:

     1. Grant of Option. The Company hereby grants to you, pursuant to the Stock Option
Plan, the option to purchase from the Company upon the terms and conditions and at the times
hereinafter set forth:

	 	(a)  	effective on the date hereof (the “Option Date”),
an aggregate of 125,000 shares of the common stock, $.0005 par value, of the Company (“Common Stock”) at a
purchase price of $5.88 per share (“Option Date Grant”); and
	 
	 	(b)  	effective on the date of commencement of your employment with the Company (the
“Commencement Date”), an aggregate of 75,000 shares of Common Stock at a purchase price
equal to the closing price of the Common Stock on that date, as reported by the Nasdaq
Stock Market (the “Commencement Date Grant”).

The shares subject to the Option Date Grant and the Commencement Date Grant are referred to herein
collectively as the “Shares.”

 

 

Dr. James M. Pusey

March 3, 2005

Page 2

 

     This option is intended to be an incentive stock option (“ISO”) to the maximum extent
permitted by law. In accordance with Internal Revenue Code rules, the aggregate fair market value
(determined as of the date of grant) of shares with respect to which ISOs are exercisable for the
first time during any calendar year (under the Plan or under any other incentive stock option plan
of the Company or Subsidiary of the Company) may not exceed $100,000. If the fair market value of
shares on the date of grant with respect to which options are exercisable for the first time during
any calendar year exceeds $100,000, then the options for the first $100,000 of shares to become
exercisable in such calendar year (in the order of Commencement Date Grant options then Option Date
Grant options) will be ISOs and the options for the amount in excess of $100,000 that become
exercisable in that calendar year will be treated as non-qualified stock options (“NSOs”).

     2. Exercisability of Option. The Option Date Grant option shall be immediately
exercisable as to 10% of the total shares covered thereby and shall become exercisable as to 1/48
of the remaining 90% for each full month of employment with the Company after the Option Date
(2,343.75 shares per month). The Commencement Date Grant option shall be immediately exercisable
upon its effectiveness as to 10% of the total shares covered thereby and shall become exercisable
as to 1/48th of the remaining 90% for each full month of employment with the Company after the
Option Date (1,406.25 shares per month). By way of example, the options will be exercisable in the
aggregate for 65,000 shares if you continue in employment for one full year, 110,000 shares if you
continue in employment for two full years, 155,000 shares if you continue in employment for three
full years and all 200,000 shares if you continue in employment for four full years. No fractional
shares shall be issued upon exercise of this option and if the application of the fractions set
forth above would result in a fractional share, the number of shares exercisable shall be rounded
up to the next full share.

     Notwithstanding the foregoing, upon a Change in Control, you shall be entitled to exercise
this option with respect to all shares covered by this option (200,000 shares); provided, however,
that if the Company shall, on or before the date of such Change of Control, request that you remain
in the employ of the Company following the Change of Control, then you shall be entitled to
exercise this option with respect to the greater of (i) 90% of the shares covered by this option
(180,000 shares) or (ii) the number of shares then exercisable as of the Change in Control, and the
remaining portion of this option shall become exercisable upon your completion of six months
service thereafter or, if earlier, the date on which the Company terminates your employment.

     For purposes of this Letter of Grant, the term “Change of Control” shall be defined as a
change in ownership or control of the Company effected through any of the following transactions:
(a) a statutory share exchange, merger, consolidation or reorganization approved by the Company’s
stockholders, unless securities representing more than 50% of the total combined voting power of
the voting securities of the successor corporation are immediately thereafter beneficially owned,
directly or indirectly, by the persons who beneficially owned the

 

 

Dr. James M. Pusey

March 3, 2005

Page 3

 

Company’s outstanding voting securities immediately prior to such transaction; (b) any
stockholder approved transfer or other disposition of all or substantially all of the Company’s
assets (whether held directly or indirectly through one or more controlled subsidiaries) except to
or with a wholly-owned subsidiary of the Company); or (c) the acquisition, directly or indirectly
by any person or related group of persons of beneficial ownership (within the meaning of Rule 13d-3
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) of securities possessing
more than 50% of the total combined voting power of the Company’s outstanding securities pursuant
to transactions with the Company’s stockholders.

     3. Termination of Option. Notwithstanding anything to the contrary herein, the extent
to which this option may be exercised shall not increase after your employment with the Company
terminates, and this option shall not be exercisable after the earliest of (i) the tenth
anniversary of the Option Date; (ii) two years after the date your employment with the Company
terminates, if such termination is for any reason other than permanent disability, death, or cause;
(iii) the date your employment terminates, if such termination is for cause; or (iv) three years
after the date your employment with the Company terminates, if such termination is the result of
death or permanent disability. For purposes of this Letter of Grant, cause shall be determined
pursuant to your employment agreement then in effect and if you are not then subject to an
employment agreement, in the Company’s reasonable discretion. You acknowledge that any incentive
stock options exercised more than 90 days after the date on which your employment terminates (one
year in the case of termination due to death or permanent disability), shall no longer qualify as
incentive stock options under the Internal Revenue Code.

     4. Nontransferability. This option shall not be transferable otherwise than by will
or by the laws of descent and distribution, and the options shall be exercisable only by (a) you,
during your lifetime (except as contemplated by the next clause); or (b) your legal representative
or a person who acquired the right to exercise these options by bequest or inheritance, during the
three-year period referred to in Section 3(iv) hereof. Any attempted transfer in violation of this
restriction shall be void.

     5. Other Conditions and Limitations. Unless the Shares are subject to a then
effective registration statement under the Securities Act of 1933, upon exercise of this option (in
whole or in part) and the issuance of the Shares, the Company shall instruct its transfer agent to
enter stop transfer orders with respect to Shares, and all certificates representing the Shares
shall bear on the face thereof substantially the following legend:

“The shares of common stock represented by this certificate have not been
registered under the Securities Act of 1933, as amended, and may not be sold,
offered for sale, assigned, transferred or otherwise disposed of unless registered
pursuant to the provisions of that Act or an opinion of counsel to the Company is
obtained stating that such disposition is in compliance with an available exemption
from such registration.”

 

 

Dr. James M. Pusey

March 3, 2005

Page 4

 

     6. Exercise of Option. You may exercise the option including the number of Shares
that you are intending to acquire, accompanied by the full exercise price, only by giving the
Company written notice by personal hand delivery, by professional overnight delivery service, or by
registered or certified mail, postage prepaid with return receipt requested, at the following
address:

Chief Financial Officer

OrthoLogic Corp.

1275 West Washington Street

Tempe, AZ 85281

     Payment of the option price shall be made either in (i) cash or by check, or (ii) at your
request and with the approval of the Company, by delivering shares of the Company’s common stock
which have been beneficially owned by you for a period of at least six months prior to the time of
exercise (“Delivered Stock”) or a combination of cash and Delivered Stock. Payment in the form of
Delivered Stock shall be in the amount of the fair market value of the stock at the date of
exercise, determined pursuant to the Stock Option Plan.

     7. Valuation and Withholding. If required by applicable regulations, the Company
shall, at the time of issuance of any Shares purchased pursuant to the Stock Option Plan, provide
you with a statement of valuation of the Shares issued. The Company shall be entitled to withhold
amounts from your compensation or otherwise to receive an amount adequate to provide for any
applicable federal, state and local income taxes (or require you to remit such amount as a
condition of issuance). The Company may, in its discretion, satisfy any such withholding
requirement, in whole or in part, by withholding from the shares to be issued the number of shares
that would satisfy the withholding amount due.

     8. Notice of Disposition of Shares. If you dispose of any Shares acquired upon the
exercise of the portion of the option treated as an ISO within either (a) two years after the
Option Date or (b) one year after the date of exercise of this option, you must notify the Company
within seven days of such disposition.

     9. Miscellaneous. You will have no rights as a stockholder with respect to the Shares
until the exercise of the option and payment of the full purchase price therefor in accordance with
the terms of the Stock Option Plan and this Letter of Grant. Nothing herein contained shall impose
any obligation on the Company or any parent or subsidiary of the Company or on you with respect to
your continued employment by the Company or any parent or subsidiary of the Company. Nothing
herein contained shall impose any obligation upon you to exercise this option. While a portion of
the option granted hereunder is intended to qualify as an incentive stock option under Code Section
422, the Company cannot assure you that such option will, in fact, qualify as incentive stock
options, and makes no representation as to the tax

 

 

Dr. James M. Pusey

March 3, 2005

Page 5

 

treatment to you upon receipt or exercise of the option or sale or other disposition of the
Shares covered by the option.

     10. Governing Law. This Letter of Grant shall be subject to and construed in
accordance with the law of the State of Arizona, except as may be required by the Delaware General
Corporation Law or the federal securities laws. Venue for any action arising from or relating to
this Agreement shall lie exclusively in Superior Court, Maricopa County, Arizona or the United
States District Court for the District of Arizona, Phoenix Division.

     11. Relationship to the Stock Option Plan. The option contained in this Letter of
Grant is subject to the terms, conditions and definitions of the Stock Option Plan. To the extent
that the terms, conditions and definitions of this Letter of Grant are inconsistent with the terms,
conditions and definitions of the Stock Option Plan, the terms, conditions and definitions of the
Stock Option Plan shall govern. You hereby accept this option subject to all terms and provisions
of the Stock Option Plan. You agree to accept as binding, conclusive and final all decisions or
interpretations of the Board or any committee appointed by the Board upon any questions arising
under the Stock Option Plan, absent fraud or manifest error. You agree to consult your independent
tax advisors with respect to the income tax consequences to you, if any, of participating in the
Stock Option Plan and authorize the Company to withhold in accordance with applicable law from any
compensation otherwise payable to you any taxes required to be withheld by federal, state or local
law as a result of your participation in the Stock Option Plan.

     12. Communication. No notice or other communication under this Letter of Grant shall
be effective unless the same is in writing and is personally hand-delivered, or is sent by
professional overnight delivery service or mailed by registered or certified mail, postage prepaid
and with return receipt requested, addressed to:

	 	(a)  	the Company at the address set forth in Section 6 above, or such other address
as the Company has designated in writing to you, in accordance with the provisions
hereof, or
	 
	 	(b)  	you at the address set forth at the beginning of this letter, or such other
address as you have designated in writing to the Company, in accordance with the
provisions hereof.

     13. Share Amounts. All share amounts set forth in this Agreement shall be equitably
adjusted to reflect stock splits, stock dividends, stock combinations, reorganizations and the
like.

     14. Counterparts. This Agreement may be executed in any number of counterparts, and
each such counterpart shall be deemed to be an original instrument, but all such counterparts
together shall constitute but one agreement. This Agreement may be executed and delivered by
facsimile.

 

 

Dr. James M. Pusey

March 3, 2005

Page 6

 

     You should execute the enclosed copy of this Letter of Grant and return it to the Company as
soon as possible. The additional copy is for your records.

	 	 	 	 	 
	 	Very truly yours,

ORTHOLOGIC CORP.

 	 
	 	By:  	/s/ Jock M. Holliman, III
 	 
	 	 	Jock M. Holliman, III 	 
	 	 	Chairman of the Board 	 
	 

	 
	ACCEPTED AND AGREED TO:

	 

	/s/ James M. Pusey

	

	James M. Pusey

	 

	Date:          03/03/2005exv10w4

 

EXHIBIT 10.4

LETTER OF STOCK OPTION GRANT

ORTHOLOGIC CORP.

March 3, 2005

Dr. James M. Pusey

OrthoLogic Corp.

1275 West Washington

Tempe, Arizona 85281

		
	     RE: 	OrthoLogic Corp. Stock Option Grant

(300,000 Shares)

Dear Dr. Pusey:

     In connection with your employment with OrthoLogic Corp. (the “Company”), the Company is
offering you a nonqualified stock option to purchase shares of Company stock. The option is
subject to the following terms and conditions:

     1. Grant of Option. The Company hereby grants to you a nonqualified stock option to
purchase from the Company upon the terms and conditions and at the times hereinafter set forth, an
aggregate of 300,000 shares of the common stock, $.0005 par value, of the Company (the “Shares”)
at a purchase price of $5.88 per Share. The date of grant of this option is March 3, 2005
(hereinafter referred to as the “Option Date”).

     2. Exercisability of Option. This option shall be immediately exercisable as to 10%
of the total shares covered by this option and shall become exercisable as to 1/48 of the remaining
90% for each full month of employment with the Company after the Option Date (5,625 shares per
month), so that, by way of example, the option will be exercisable for 107,500 shares if you
continue in employment for one full year, 165,000 shares if you continue in employment for two full
years, 232,500 shares if you continue in employment for three full years and all 300,000 shares if
you continue in employment for four full years. No fractional shares shall be issued upon exercise
of this option and if the application of the fractions set forth above would result in a fractional
share, the number of shares exercisable shall be rounded up to the next full share.

     Notwithstanding the foregoing, upon a Change in Control, you shall be entitled to exercise
this option with respect to all shares covered by this option (300,000 shares); provided, however,
that if the Company shall, on or before the date of such Change of Control, request that

 

 

Dr. James M. Pusey

March 3, 2005

Page 2

you remain in the employ of the Company following the Change of Control, then you shall be
entitled to exercise this option with respect to the greater of (i) 90% of the shares covered by
this option (270,000 shares) or (ii) the number of shares then exercisable as of the Change in
Control, and the remaining portion of this option shall become exercisable upon your completion of
six months service thereafter or, if earlier, the date on which the Company terminates your
employment.

     For purposes of this Letter of Grant, the term “Change of Control” shall be defined as a
change in ownership or control of the Company effected through any of the following transactions:
(a) a statutory share exchange, merger, consolidation or reorganization approved by the Company’s
stockholders, unless securities representing more than 50% of the total combined voting power of
the voting securities of the successor corporation are immediately thereafter beneficially owned,
directly or indirectly, by the persons who beneficially owned the Company’s outstanding voting
securities immediately prior to such transaction; (b) any stockholder approved transfer or other
disposition of all or substantially all of the Company’s assets (whether held directly or
indirectly through one or more controlled subsidiaries) except to or with a wholly-owned subsidiary
of the Company); or (c) the acquisition, directly or indirectly by any person or related group of
persons of beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”) of securities possessing more than 50% of the total combined
voting power of the Company’s outstanding securities pursuant to transactions with the Company’s
stockholders.

     3. Termination of Option. Notwithstanding anything to the contrary herein, the extent
to which this option may be exercised shall not increase after your employment with the Company
terminates, and this option shall not be exercisable after the earliest of (i) the tenth
anniversary of the Option Date; (ii) two years after the date your employment with the Company
terminates, if such termination is for any reason other than permanent disability, death, or cause;
(iii) the date your employment terminates, if such termination is for cause; or (iv) three years
after the date your employment with the Company terminates, if such termination is the result of
death or permanent disability. For purposes of this Letter of Grant, cause shall be determined
pursuant to your employment agreement then in effect and if you are not then subject to an
employment agreement, in the Company’s reasonable discretion.

     4. Registration. The Company shall use its reasonable best efforts to register with
the United States Securities and Exchange Commission within 90 days of the date hereof and maintain
in effect at all times thereafter a registration statement under the Securities Act of 1933, as
amended (the “Securities Act”), in respect of all shares issuable to you to pursuant to the options
granted hereunder; provided that this covenant shall not apply from and after the date on which you
are entitled to sell such shares pursuant to Rule 144(k) under the Securities Act.

     5. Nontransferability. This option shall not be transferable otherwise than by will
or by the laws of descent and distribution, and the options shall be exercisable only by (a) you,

 

 

Dr. James M. Pusey

March 3, 2005

Page 3

during your lifetime (except as contemplated by the next clause); or (b) your legal
representative or a person who acquired the right to exercise these options by bequest or
inheritance, during the three-year period referred to in Section 3(iv) hereof. Any attempted
transfer in violation of this restriction shall be void.

     6. Other Conditions and Limitations. Unless the Shares are subject to a then
effective registration statement under the Securities Act of 1933, upon exercise of this option (in
whole or in part) and the issuance of the Shares, the Company shall instruct its transfer agent to
enter stop transfer orders with respect to Shares, and all certificates representing the Shares
shall bear on the face thereof substantially the following legend:

“The shares of common stock represented by this certificate have not been
registered under the Securities Act of 1933, as amended, and may not be sold,
offered for sale, assigned, transferred or otherwise disposed of unless registered
pursuant to the provisions of that Act or an opinion of counsel to the Company is
obtained stating that such disposition is in compliance with an available exemption
from such registration.”

     7. Exercise of Option. You may exercise the option including the number of Shares
that you are intending to acquire, accompanied by the full exercise price, only by giving the
Company written notice by personal hand delivery, by professional overnight delivery service, or by
registered or certified mail, postage prepaid with return receipt requested, at the following
address:

Chief Financial Officer

OrthoLogic Corp.

1275 West Washington Street

Tempe, AZ 85281

     Payment of the option price shall be made either in (i) cash or by check, or (ii) at your
request and with the approval of the Company, by delivering shares of the Company’s common stock
which have been beneficially owned by you for a period of at least six months prior to the time of
exercise (“Delivered Stock”) or a combination of cash and Delivered Stock. Payment in the form of
Delivered Stock shall be in the amount of the fair market value of the stock at the date of
exercise.

     8. Valuation and Withholding. If required by applicable regulations, the Company
shall, at the time of issuance of any Shares purchased, provide you with a statement of valuation
of the Shares issued. The Company shall be entitled to withhold amounts from your compensation or
otherwise to receive an amount adequate to provide for any applicable federal, state and local
income taxes (or require you to remit such amount as a condition of issuance). The Company may, in
its discretion, satisfy any such withholding requirement, in whole or in

 

 

Dr. James M. Pusey

March 3, 2005

Page 4

part, by withholding from the shares to be issued the number of shares that would satisfy the
withholding amount due.

     9. Miscellaneous. You will have no rights as a stockholder with respect to the Shares
until the exercise of the option and payment of the full purchase price therefor in accordance with
this Letter of Grant. Nothing herein contained shall impose any obligation on the Company or any
parent or subsidiary of the Company or on you with respect to your continued employment by the
Company or any parent or subsidiary of the Company. Nothing herein contained shall impose any
obligation upon you to exercise this option.

     10. Governing Law. This Letter of Grant shall be subject to and construed in
accordance with the law of the State of Arizona, except as may be required by the Delaware General
Corporation Law or the federal securities laws. Venue for any action arising from or relating to
this Agreement shall lie exclusively in Superior Court, Maricopa County, Arizona or the United
States District Court for the District of Arizona, Phoenix Division.

     11. Communication. No notice or other communication under this Letter of Grant shall
be effective unless the same is in writing and is personally hand-delivered, or is sent by
professional overnight delivery service or mailed by registered or certified mail, postage prepaid
and with return receipt requested, addressed to:

	 	(a)  	the Company at the address set forth in Section 7 above, or such other address
as the Company has designated in writing to you, in accordance with the provisions
hereof, or
	 
	 	(b)  	you at the address set forth at the beginning of this letter, or such other
address as you have designated in writing to the Company, in accordance with the
provisions hereof.

     12. Share Amounts. All share amounts set forth in this Agreement shall be equitably
adjusted to reflect stock splits, stock dividends, stock combinations, reorganizations and the
like.

     13. Counterparts. This Agreement may be executed in any number of counterparts, and
each such counterpart shall be deemed to be an original instrument, but all such counterparts
together shall constitute but one agreement. This Agreement may be executed and delivered by
facsimile.

 

 

Dr. James M. Pusey

March 3, 2005

Page 5

     You should execute the enclosed copy of this Letter of Grant and return it to the Company as
soon as possible. The additional copy is for your records.

	 	 	 	 	 
	 	Very truly yours,

ORTHOLOGIC CORP.

 	 
	 	By:  	/s/ Jock M. Holliman, III
 	 
	 	 	Jock M. Holliman, III 	 
	 	 	Chairman of the Board 	 
	 

ACCEPTED AND AGREED TO:

	 	 	 	 	 
	/s/ James M. Pusey	 	 
	 	 	 
	James M. Pusey	 	 
	 
	 	 	 	 
	Date:

	 	03/03/2005

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]